Tigermed
Charlotte Chuan began their work experience in 2019 as an Associate Director of Clinical Research at Athenex. Charlotte was then promoted to Director of Clinical Research in March 2021. During their time at Athenex, they successfully led the team in passing regulatory inspections for an oncology study and facilitated a smooth transition in the CR Department by bringing in new talent. In 2021, they joined Tigermed as an Associate Global Project Director.
Charlotte Chuan completed their Bachelor of Pharmacy degree at Taipei Medical University in Taiwan from 1999 to 2003. Charlotte then pursued a Master of Science degree in Pharmacotherapy and Medicines Management at the University of Sunderland in the UK from 2006 to 2007.
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.